IFNA17 and type 1 diabetes mellitus: The current literature suggests that type I IFNs in T1D, specifically IFN-α, either upregulate the PD-1/PD-L pathway or cause lipid dysregulation, impairing the immune response against M. tuberculosis (Figure 2).